Table 1 Clinical characteristics
From: BK-UM in patients with recurrent ovarian cancer or peritoneal cancer: a first-in-human phase-I study
Patient no. | Cancer subtype | Previous chemotherapy | Previous radiotherapy | PS |
|---|---|---|---|---|
1 | OVCA (EMC) | 5 lines | None | 1 |
2 | OVCA (SCC) | 2 lines | None | 1 |
3 | OVCA (SCC) | 2 lines | None | 1 |
4 | OVCA (SCC) | 1 lines | γ-knife | 1 |
5 | PC (SCC) | 2 lines | None | 1 |
6 | OVCA (SCC) | 3 lines | None | 1 |
7 | OVCA (SCC) | 8 lines | None | 0 |
8 | OVCA (SCC) | 7 lines | None | 1 |
9 | OVCA (SCC) | 4 lines | None | 1 |
10 | OVCA (CCC) | 5 lines | None | 1 |
11 | OVCA (TCC) | 4 lines | None | 0 |